Evidence map›Paper›PMID 26416712›Full record

ArticleAnnals of surgical oncology2016

Microcalcifications in 1657 Patients with Pure Ductal Carcinoma in Situ of the Breast: Correlation with Clinical, Histopathologic, Biologic Features, and Local Recurrence.

Gaiane M Rauch, Brian P Hobbs, Henry M Kuerer, Marion E Scoggins, Ana P Benveniste, Young Mi Park, Abigail S Caudle, Patricia S Fox, Benjamin D Smith, Beatriz E Adrada and 2 more

Open access · greenAbstract read
In one paragraph

Article in Annals of surgical oncology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 57 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Observational
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Gaiane M RauchDepartment of Diagnostic Radiology, Unit 1473, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. gmrauch@mdanderson.org.
Brian P HobbsDepartment of Biostatistics, Unit 1411, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Henry M KuererDepartment of Surgical Oncology, Unit 1434, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Marion E ScogginsDepartment of Diagnostic Radiology, Unit 1350, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Ana P BenvenisteDepartment of Diagnostic Imaging, Unit 1476, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Young Mi ParkDepartment of Diagnostic Imaging, Unit 1476, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Abigail S CaudleDepartment of Surgical Oncology, Unit 1434, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Patricia S FoxDepartment of Biostatistics, Unit 1411, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Benjamin D SmithDepartment of Radiation Oncology, Unit 1202, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Beatriz E AdradaDepartment of Diagnostic Radiology, Unit 1350, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Savitri KrishnamurthyDepartment of Pathology Administration, Unit 0053, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Wei T YangDepartment of Diagnostic Radiology, Unit 1459, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
The University of Texas MD Anderson Cancer Center · US

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Scott Kopetz · 1985 to 2026
$290.8M
NCI NIH HHS P30 CA016672NCI NIH HHS P30CA016672
6 · The paper itself

Abstract

purposeThis study was designed to determine the relationship of microcalcification morphology and distribution with clinical, histopathologic, biologic features, and local recurrence (LR) in patients with pure ductal carcinoma in situ (DCIS) of the breast.

methodsAll patients with pure DCIS who underwent preoperative mammography at our institution from 1996 through 2009 were identified. Mammographic findings were classified according to the ACR BI-RADS lexicon. Associations between mammographic findings and clinical, histopathologic, biologic characteristics, and LR were analyzed. Statistical inference used multiple logistic regression and Cox proportional hazards regression adjusted for age and confounding due to bias from nonrandomized selection of radiation therapy.

resultsWe identified 1657 patients with microcalcifications visualized on mammography. The mean age at diagnosis was 55 years (SD, 11). The mean follow-up was 7 years (range 1-16). Ipsilateral LR was 4 % in segmentectomy (987) and 1.5 % in mastectomy (670) patients. Increased LR risk was seen in patients with dense breast tissue (p < 0.05) and larger DCIS size (p < 0.01). Radiation therapy was associated with a 2.8-fold decrease in the LR risk. Fine linear (branching) microcalcifications were associated with 5.2-fold increase in LR. Extremely dense breast tissue was associated with positive/close margins (p = 0.04) and multicentricity (p < 0.01). Younger women were more likely to have extremely dense breast tissue (p < 0.0001), multicentric disease (p < 0.0004), and undergo mastectomy (p < 0.0001).

conclusionsDense breast tissue, large DCIS size, and fine linear (branching) microcalcifications were associated with increased LR, yet overall LR rates remained low. Extremely dense breast tissue was a risk factor for multicentricity and positive margins in DCIS.

Indexed as

Breast NeoplasmsCalcinosisCarcinoma, Ductal, BreastCarcinoma, Intraductal, NoninfiltratingFemaleFollow-Up StudiesHumansIncidenceMammographyMastectomyMastectomy, SegmentalMiddle AgedNeoplasm Recurrence, LocalNeoplasm StagingPrognosisRisk Factors

Identifiers

PMID26416712
PMCPMC5040326
OpenAlexW1802093347

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.